Skip to content

Treatment of amblyopia with atropine

Treatment of amblyopia with atropine - Atropine treatment

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000044731
Enrollment
30
Registered
2021-07-02
Start date
2021-07-02
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

amblyopia

Interventions

None listed

Sponsors

Hiroshima University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: who can do visual acuity test

Exclusion criteria

Exclusion criteria: atropin allergey

Design outcomes

Primary

MeasureTime frame
Visual acuity

Countries

Japan

Contacts

Public ContactKaori Komatsu

Hiroshima University Hospital Ophthalmology

kaori110@hiroshima-u.ac.jp0822575247

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026